Five Infections Linked to More Than 2 Million Cancer Cases

Five common infections may be associated with more than 2 million new cancer cases worldwide each year, according to media coverage of a global study. The estimate highlights an important public health opportunity: some infection-related cancers can be reduced through vaccination, screening, testing, and treatment.

The figure represents an estimated population-level burden. It does not mean that every person with one of these infections will develop cancer. Most infections do not lead to cancer, and individual risk depends on factors such as persistent infection, age, immune function, genetics, tobacco and alcohol use, environmental exposure, and access to healthcare.

ScienceAlert reported that five infections collectively account for more than 2 million new cancer cases globally each year (Source 1). Other reports described the finding as approximately one in eight cancer cases worldwide, although the supplied coverage does not include the complete study methodology or publication details (Source 2, Source 3, and Source 4).

The commonly recognized infection-related cancer agents are human papillomavirus, Helicobacter pylori, hepatitis B virus, hepatitis C virus, and Epstein–Barr virus. The exact list, study year, cancer definitions, and calculations should be verified against the original peer-reviewed research before publication.

What the Estimate Means

An infection-attributable cancer estimate measures the number of cancer cases statistically linked to an infection in a population. It is not a count of people currently infected, and it does not mean that infection was the only cause of each cancer.

Key terms include:

• Infection prevalence: The number of people who have an infection.
• Persistent infection: An infection that remains in the body for an extended period.
• Infection-attributable cancer: Cancer cases estimated to result from an infection.
• Total cancer incidence: All newly diagnosed cancer cases, regardless of cause.

Media reports describing the estimate as approximately one in eight cancer cases worldwide may be relying on specific study years, cancer definitions, and statistical methods. The original research should remain the primary authority.

How Infections May Contribute to Cancer

Persistent infections may increase cancer risk through chronic inflammation, tissue damage, repeated injury and repair, genetic changes, altered immune responses, or disruption of normal cell-growth controls. Some viruses interfere with tumor-suppressor pathways or make it harder for the immune system to eliminate abnormal cells.

Infection is only one possible risk factor. Tobacco use, alcohol consumption, obesity, age, genetics, immune status, environmental exposures, and limited access to screening can also influence cancer risk.

A population estimate cannot predict what will happen to one person. Many people infected with HPV, H. pylori, hepatitis viruses, or EBV never develop cancer.

The Five Infections

Human Papillomavirus

Human papillomavirus, or HPV, is a common sexually transmitted infection. Most infections clear naturally, but persistent infection with high-risk HPV types can cause abnormal cellular changes.

High-risk HPV is strongly associated with cervical cancer and is also linked to anal, penile, vulvar, vaginal, and some head and neck cancers.

HPV vaccination helps prevent new infections with cancer-causing HPV types but does not treat an existing infection. Cervical screening can detect HPV or precancerous cellular changes before invasive cancer develops. Safer sexual practices can reduce transmission risk but cannot provide complete protection because HPV can spread through skin-to-skin contact.

Helicobacter pylori

Helicobacter pylori, commonly called H. pylori, is a bacterium that can colonize the stomach. Many infected people have no symptoms, while others develop chronic gastritis, ulcers, or recurring stomach discomfort.

Long-term infection can damage the stomach lining and increase the risk of stomach cancer. It is also associated with gastric mucosa-associated lymphoid tissue lymphoma.

Testing may involve a breath test, stool test, blood test in some settings, or endoscopic biopsy. Confirmed infection is generally treated with antibiotics and acid-reducing medicines. Treatment should be prescribed by a clinician because antibiotic resistance affects which medicines are effective.

Hepatitis B Virus

Hepatitis B virus can cause acute or chronic liver infection. Chronic infection may lead to inflammation, fibrosis, cirrhosis, liver failure, and hepatocellular carcinoma, the most common primary liver cancer.

Prevention includes vaccination, safe injection practices, screened blood products, and measures that reduce exposure to infected blood or bodily fluids. Testing during pregnancy can help healthcare teams reduce transmission to a newborn.

People with chronic hepatitis B may need long-term monitoring even when they feel healthy. Antiviral treatment can reduce complications for some patients but does not eliminate the need for follow-up.

Hepatitis C Virus

Hepatitis C can silently damage the liver over many years. Chronic inflammation may progress to fibrosis and cirrhosis, increasing the risk of liver cancer.

Common exposure routes include sharing injection equipment, unsafe medical procedures, and tattooing or piercing with unsterilized equipment. Highly effective direct-acting antiviral medicines cure most hepatitis C infections. There is currently no widely used hepatitis C vaccine.

People with advanced liver scarring may still need liver cancer surveillance after the virus has been cured.

Epstein–Barr Virus

Epstein–Barr virus, or EBV, is widespread. Many infections cause no symptoms, while others cause infectious mononucleosis.

EBV is associated with selected cancers, including nasopharyngeal carcinoma, certain lymphomas, and some stomach cancers. Risk depends on viral persistence, immune function, genetics, geography, and environmental exposures. Cancer associated with EBV is uncommon compared with the total number of EBV infections.

There is no routinely available EBV vaccine. A positive EBV test does not diagnose cancer because the virus is common in the general population.

Why the Findings Matter

Many infection-related cancers may be preventable through:

• HPV vaccination.
• Hepatitis B vaccination.
• Cervical cancer screening.
• Hepatitis B and hepatitis C testing.
• Direct-acting antiviral treatment for hepatitis C.
• Appropriate diagnosis and eradication of H. pylori.

The benefits are not distributed equally. Some regions face lower vaccination coverage, limited screening, inadequate diagnostic services, and reduced access to antiviral or antibiotic treatment. Expanding affordable vaccination, testing, screening, and treatment could reduce preventable cancer cases over time.

The estimate supports prevention, not panic. These infections are common, but infection-related cancer is not inevitable.

How to Reduce Risk

• Keep recommended HPV and hepatitis B vaccinations current.
• Follow local cervical screening guidance and complete follow-up after abnormal results.
• Ask a healthcare professional whether hepatitis B, hepatitis C, or H. pylori testing is appropriate.
• Do not share needles, syringes, razors, or toothbrushes.
• Use licensed facilities for tattoos and piercings.
• Practice safer sex and ensure medical equipment is sterile.
• Seek medical evaluation for unexplained weight loss, unusual bleeding, difficulty swallowing, ongoing abdominal pain, jaundice, persistent swollen lymph nodes, repeated vomiting, or abdominal swelling.

These symptoms do not automatically indicate cancer. They may reflect a treatable infection or another condition.

What the Estimate Does Not Prove

The reported estimate does not prove that:

• Every person with one of these infections will develop cancer.
• Infection is the only cause of an individual cancer.
• All cancers can be prevented through infection control.
• A positive infection test is a cancer diagnosis.
• Every media report uses the same definitions or study period.
• Vaccination, treatment, or screening eliminates all cancer risk.

The final version should prioritize the original research paper or an institutional source and verify the infection list, study year, cancer totals, and statistical methods.

Frequently Asked Questions

Can an infection directly cause cancer?

Some persistent infections can increase cancer risk through chronic inflammation, cellular changes, immune effects, or tissue damage. Infection does not guarantee cancer and is usually one factor in a complex process.

What are the five infections linked to millions of cancer cases?

The commonly recognized agents are human papillomavirus, Helicobacter pylori, hepatitis B virus, hepatitis C virus, and Epstein–Barr virus. The exact list should be checked against the original research paper.

How many cancer cases are linked to these infections each year?

The supplied ScienceAlert report describes more than 2 million new cancer cases globally each year. Estimates vary according to the study year, cancer definitions, geographic coverage, and calculation methods.

Can vaccines prevent infection-related cancers?

HPV and hepatitis B vaccination can reduce the risk of cancers associated with those infections. Vaccines do not prevent every cancer or treat established infections.

Can hepatitis C be cured?

Modern direct-acting antiviral medicines cure most hepatitis C infections. People with advanced liver damage may still need ongoing liver cancer surveillance after treatment.

Should everyone be tested for these infections?

Testing recommendations differ by infection, country, age, pregnancy status, symptoms, and exposure history. A qualified healthcare professional can recommend appropriate tests.

Conclusion

Five common infections may be linked to more than 2 million new cancer cases worldwide each year. The commonly recognized agents are HPV, H. pylori, hepatitis B virus, hepatitis C virus, and EBV, although the final list and estimates should be confirmed against the primary study.

The practical response is prevention: receive recommended vaccines, complete cervical screening, ask about appropriate infection testing, treat confirmed infections, and seek medical care for persistent symptoms. Infection-related cancer risk is significant, but many prevention opportunities are already available.